A kit and method for detecting chromosome heterozygosity loss based on amplicon sequencing
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- 艾普拜生物科技(苏州)有限公司
- Publication Date
- 2019-11-19
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of nucleic acid detection in molecular biology, and relates to a kit and a method for detecting chromosome heterozygosity loss based on an amplicon sequencing method. Background technique
[0002] Glioma originating from glial cells is the most common primary intracranial tumor, accounting for about 27% of all central nervous system tumors and about 80% of malignant tumors. The annual incidence of glioma in my country is (3-6.4) / 100,000, and the annual death toll reaches 30,000. The incidence rate of malignant glioma (Glioblastoma, GBM, WHO grade IV) is 5.8 / 100,000, and the 5-year mortality rate is second only to pancreatic cancer and lung cancer among systemic tumors, ranking third. Oligodendroglioma accounts for 5-18% of glioma, and is an independent type of glioma. Most oligodendroglial tumors have loss of heterozygosity (Loss of Heterozygosity, LOH) of the short arm of chromosome 1 (1p) and the long arm of chrom...